"Penicillanic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed)
| Descriptor ID |
D010397
|
| MeSH Number(s) |
D02.065.589.099.750.687 D02.886.108.750.687 D03.633.100.300.750.687
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Penicillanic Acid".
Below are MeSH descriptors whose meaning is more specific than "Penicillanic Acid".
This graph shows the total number of publications written about "Penicillanic Acid" by people in this website by year, and whether "Penicillanic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 11 | 11 | 22 |
| 2018 | 3 | 1 | 4 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Penicillanic Acid" by people in Profiles.
-
Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective Study. Clin Infect Dis. 2020 05 23; 70(11):2270-2280.
-
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial. JAMA. 2018 09 11; 320(10):984-994.
-
Nephrotoxicity of piperacillin/tazobactam combined with vancomycin: should it be a concern? Int J Antimicrob Agents. 2018 Aug; 52(2):180-184.
-
Which non-carbapenem antibiotics are active against extended-spectrum ß-lactamase-producing Enterobacteriaceae? Int J Antimicrob Agents. 2018 Jul; 52(1):100-103.
-
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial. JAMA. 2018 02 27; 319(8):788-799.
-
Appropriate non-carbapenems are not inferior to carbapenems as initial empirical therapy for bacteremia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a propensity score weighted multicenter cohort study. Eur J Clin Microbiol Infect Dis. 2018 Feb; 37(2):305-311.
-
Mechanisms of proton relay and product release by Class A ß-lactamase at ultrahigh resolution. FEBS J. 2018 01; 285(1):87-100.
-
Antibiotic Resistance in Diabetic Foot Soft Tissue Infections: A Series From Greece. Int J Low Extrem Wounds. 2017 Dec; 16(4):255-259.
-
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant. Infection. 2018 Apr; 46(2):263-265.
-
Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain. Antimicrob Agents Chemother. 2017 11; 61(11).